Estrogen regulation and physiopathologic significance of alternative promoters in breast cancer.
about
Dual role of the ddx5/ddx17 RNA helicases in the control of the pro-migratory NFAT5 transcription factorThe RNA helicase DDX5/p68 is a key factor promoting c-fos expression at different levels from transcription to mRNA exportCell-context dependent TCF/LEF expression and function: alternative tales of repression, de-repression and activation potentialsDEAD box RNA helicase functions in cancerAcetylation of the RhoA GEF Net1A controls its subcellular localization and activity.Rac1 controls the subcellular localization of the Rho guanine nucleotide exchange factor Net1A to regulate focal adhesion formation and cell spreadingThe Ddx5 and Ddx17 RNA helicases are cornerstones in the complex regulatory array of steroid hormone-signaling pathwaysIdentification of novel androgen-regulated pathways and mRNA isoforms through genome-wide exon-specific profiling of the LNCaP transcriptome.Deep sequencing reveals new aspects of progesterone receptor signaling in breast cancer cellsThe RhoGEF Net1 is required for normal mammary gland development.The effect of heterogeneous Transcription Start Sites (TSS) on the translatome: implications for the mammalian cellular phenotype.HOXB7 Is an ERα Cofactor in the Activation of HER2 and Multiple ER Target Genes Leading to Endocrine Resistance.ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma.Genome-wide activation of latent donor splice sites in stress and disease.Bromodomain protein BRD4 is required for estrogen receptor-dependent enhancer activation and gene transcriptionMinireview: Mouse Models of Rho GTPase Function in Mammary Gland Development, Tumorigenesis, and MetastasisExpression of androgen receptor splice variants in clinical breast cancers.Regulation of focal adhesion kinase activation, breast cancer cell motility, and amoeboid invasion by the RhoA guanine nucleotide exchange factor Net1.Regulation of RhoA activation and cytoskeletal organization by acetylation.Transcriptome sequencing uncovers a three-long noncoding RNA signature in predicting breast cancer survival.Timing is everything: Rac1 controls Net1A localization to regulate cell adhesionRho GTPase-independent regulation of mitotic progression by the RhoGEF Net1Estrogen regulates miRNA expression: implication of estrogen receptor and miR-124/AKT2 in tumor growth and angiogenesis.CTCF and CTCFL mRNA expression in 17β-estradiol-treated MCF7 cells.RNA helicases p68 and p72: multifunctional proteins with important implications for cancer development.Controlling the switches: Rho GTPase regulation during animal cell mitosis.A novel androgen-regulated isoform of the TSC2 tumour suppressor gene increases cell proliferation.Genomic profiling of ER+ breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance.Rho GTPase independent regulation of ATM activation and cell survival by the RhoGEF Net1A.Functional roles of CTCF in breast cancer.Stress activated MAPKs and CRM1 regulate Net1A subcellular localization to control cell motility and invasion.Whole-transcriptome splicing profiling of E7.5 mouse primary germ layers reveals frequent alternative promoter usage during mouse early embryogenesis.Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.Androgen-dependent alternative mRNA isoform expression in prostate cancer cells
P2860
Q24302553-0EA66CF4-F1F9-455D-88B9-C72531CE11A8Q24303469-5FD3704E-D1D9-41CB-AAFB-738CD5F3B708Q27022532-9876FE85-603F-4244-A746-1799C6451D42Q27026107-11C8828F-FB77-4C15-B7B9-A9CF7AFABCF1Q27342486-D9166A3A-E46E-4D1F-9DFB-0A54D43261FEQ28592646-5EC9D5C2-D1B3-4EFF-9B7D-27994BBA3094Q28854594-5851690A-5D56-4B42-8C55-A2CBE9831732Q31043876-66F72FDB-3311-42B5-BF71-F6E6DDAF8AF3Q33711732-DFF35C67-A7DA-4220-A3AF-406A48A946D7Q34603102-B46EDF2E-BB71-49CE-A7B9-1BF4D9058B70Q35847578-66EDCF8B-46C3-4A20-A21F-475577E78654Q36029524-5A901149-41E2-4AA2-85F3-27A9C184B781Q36414073-B4A7C84A-13DA-4EC7-9A69-F2A058C95A44Q36435088-BD5D34B7-1911-42E7-85AB-42E771F4DA05Q36561822-8A32708C-1F79-4CBF-8B68-5F97194FB420Q36632432-BC407866-2A50-441B-A2CC-3043757FEED3Q36689084-5B4C772A-8ED2-417F-8DA1-3B4482E51DE4Q36978333-29B39EC4-C5FC-4822-80CC-EAEDFDC77A5DQ36997835-F61C891C-7338-483D-8466-8993FECE5B8CQ37034875-599C81B7-70DE-4E8F-B293-5A36868E36EAQ37085734-0631A400-470E-49F2-A7F0-7EB6C221B4C7Q37131476-96B34502-2254-4FAC-867E-DE324E618448Q37392880-760A011B-6893-498B-996F-97265698556FQ37567667-83D6E5CD-7CFE-40CC-9DD5-EDD06DB8AC4DQ37846229-2969D752-EBE1-4306-ABD5-BA1D3D22DBB8Q38257062-7CFD127B-EE04-43E7-A34D-84F7AEA51325Q38365327-27872F99-D16B-44FB-A60B-1B209B04C941Q38631621-B8AFEDAF-7CEB-4935-89ED-17CD12256404Q41716207-11E0B780-2051-4226-96C4-73746A0AD40DQ42369328-2B552C46-B698-4317-9B1C-6AD7F7048EEFQ48183688-7D188CC4-697E-4118-928F-35192C1B0AC3Q52723519-240CBA5B-BEE3-4D5A-9254-E3386863FD28Q55431818-4897018C-CB11-4044-9583-BDE6320A9225Q57135534-0225F187-CACC-41BF-B8EB-9B7E1A08FB4C
P2860
Estrogen regulation and physiopathologic significance of alternative promoters in breast cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Estrogen regulation and physio ...... ve promoters in breast cancer.
@en
type
label
Estrogen regulation and physio ...... ve promoters in breast cancer.
@en
prefLabel
Estrogen regulation and physio ...... ve promoters in breast cancer.
@en
P2093
P1433
P1476
Estrogen regulation and physio ...... ive promoters in breast cancer
@en
P2093
Etienne Dardenne
Keltouma Driouch
Lise Gratadou
Pierre de la Grange
Rosette Lidereau
Samaan Samaan
Sophie Germann
P304
P356
10.1158/0008-5472.CAN-09-3988
P407
P577
2010-04-20T00:00:00Z